Scarica l'app Stockscreener
20.00
0.20%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché STVN Giù?
Forum
Previsione
Storia dei dividendi
Stevanato Group Spa Borsa (STVN) Ultime notizie
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On - GuruFocus.com
Stevanato Group (NYSE:STVN) vs. Todos Medical (OTCMKTS:TOMDF) Financial Contrast - Defense World
Stevanato Group (NYSE:STVN) Stock Price Down 0.4%Here's Why - MarketBeat
Objective long/short (STVN) Report - Stock Traders Daily
Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com
Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com
Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com
Pharmaceutical Visual Inspection Systems Market Report: - openPR
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance
Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian
Stevanato Group to Present at Three Major Healthcare Investor Conferences in Q4 | STVN Stock News - StockTitan
Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group
Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com
Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St
Medical devices assembly lines - Stevanato Group
Stevanato Group S.p.A. (NYSE:STVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Citi maintains buy on Stevanato Group with $28 target - Investing.com India
Earnings call: Stevanato Group reports modest growth, eyes future recovery - Investing.com
Stevanato Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Customized in-vitro diagnostic consumable - Stevanato Group
In-Vitro Diagnostics (IVD) and Medical Solutions - Stevanato Group
Secondary packaging lines for the pharma industry - Stevanato Group
Drug Delivery systems and solutions - Stevanato Group
Drug containment solutions: Pharmaceutical glass containers - Stevanato Group
Stevanato Group Q3 2024 Earnings Overview - TipRanks
Citi maintains buy on Stevanato Group with $28 target By Investing.com - Investing.com UK
Stevanato Group SpA earnings missed by €0.02, revenue topped estimates - Investing.com
Stevanato Group (STVN) Q3 Earnings Match Estimates - Yahoo Canada Finance
Stevanato: Q3 Earnings Snapshot - San Antonio Express-News
Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian
(STVN) Trading Signals - Stock Traders Daily
What's Next: Stevanato Gr's Earnings Preview - Benzinga
Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
(STVN) On The My Stocks Page - Stock Traders Daily
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt - Simply Wall St
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 - Business Wire
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers - Smartkarma
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Squarepoint Ops LLC Purchases 6,853 Shares of Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Pharmaceutical Visual Inspection Systems Market: Detailed - openPR
The Manufacturers Life Insurance Company Boosts Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Check Out Stevanato Group Spa (STVN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Financial Fitness Check: Examining Stevanato Group Spa (STVN)’s Key Ratios - The Dwinnex
Stevanato Group Spa (STVN)’s stock price in review: A technical analysis - US Post News
Stevanato Group Introduces Large-Volume Vertiva On-Body Delivery System - Contract Pharma
Stevanato Group Spa (STVN) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Market Recap Check: Stevanato Group Spa (STVN)’s Negative Finish at 20.00, Up/Down -6.24 - The Dwinnex
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan - StockTitan
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors? - Insider Monkey
Sei Investments Co. Trims Stake in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):